Hylartil Vet 10 mg/ml Solution for Injection

국가: 영국

언어: 영어

출처: VMD (Veterinary Medicines Directorate)

유효 성분:

Sodium Hyaluronate

제공처:

Zoetis UK Limited

ATC 코드:

QM09AX01

INN (국제 이름):

Sodium Hyaluronate

약제 형태:

Solution for injection

처방전 유형:

POM-V - Prescription Only Medicine – Veterinarian

치료 그룹:

Horses

치료 영역:

Anti Inflammatory

승인 상태:

Expired

승인 날짜:

1994-07-19

제품 특성 요약

Revised: April 2014
AN: 01715/2013
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
HYLARTIL VET 10 mg/ml Solution for Injection
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 2ml syringe contains:
ACTIVE SUBSTANCE:
Sodium Hyaluronate
(MrM, mean relative molecular mass ≥ 3.0 x106) 20.00 mg (10mg/ml)
For full list of excipients, see Section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection.
4.
CLINICAL PARTICULARS
4.1.
TARGET SPECIES
Horses.
4.2.
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Hylartil Vet (10mg/ml) is indicated for use in horses as follows:
i)
For the local treatment of non-infectious inflammatory joint
disease in horses.
ii)
For the local treatment of tendinitis in horses.
4.3.
CONTRAINDICATIONS
None.
4.4.
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None known.
4.5.
SPECIAL PRECAUTIONS FOR USE
Please note the syringe is sealed with a membrane which must be
ruptured prior to use (see directions in carton).
i)
Special precautions for use in animals
None known.
Revised: April 2014
AN: 01715/2013
Page 2 of 4
ii)
Special precautions to be taken by the person administering
the veterinary medicinal product to animals
Directly after use of this product, hands and exposed skin
should be washed thoroughly.
4.6.
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Transient swelling may occur at the injection site.
4.7.
USE DURING PREGNANCY, LACTATION OR LAY
Hylartil Vet can, as far is known, be used during pregnancy and
lactation.
4.8.
INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
None known.
4.9.
AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
For intra-articular use and direct injection into tendons.
Two ml (20 mg) of Hylartil Vet is given intra-articularly in small and
medium size joints and can also be injected directly into tendons. In
the
treatment of larger joints/tendons the dosage may be increased to 4 ml
(40 mg). The injection should be given under strict aseptic
conditions.
The treatment may be repeated at weekly intervals f